Skip to content
Mukka Proteins logo

Mukka Proteins IPO

MainboardListedFood & Agro
Check allotment status
Issue price
₹28
Listing price
₹40
+42.86%
Current price
₹26.49
-5.39%
Subscribed
136.99x
Issue size
₹224 Cr
Listed on
7 Mar 2024

IPO timeline

  1. Opens
    29 FebThu
  2. Closes
    4 MarMon
  3. Allotment
    5 MarTue
  4. Refunds
    6 MarWed
  5. Demat credit
    6 MarWed
  6. Listing
    7 MarThu

Issue details

Price band
₹26 – ₹28 per share
Issue size
₹224 Cr
Fresh issue
₹224 Cr · 8 Cr shares
Offer for sale
None
Issue type
Fresh capital only
Face value
₹1 per share
Lot size
535 shares
Minimum investment
₹14,980
Listing on
BSE, NSE
Exchange code
MUKKA · 544135

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)1535₹14,980
Retail (Max)136,955₹1,94,740
S-HNI (Min)147,490₹2,09,720
B-HNI (Min)6735,845₹10,03,660

Reservation

QIB
4,00,00,000 shares (50.00% of the Offer)
NII
1,20,00,000 shares (15.00% of the Offer)
Retail
2,80,00,000 shares (35.00% of the Offer)

Allotment status

Registrar: Cameo Corporate Services Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on Cameo Corporate Services
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
5 Mar 2024
Refunds initiated
6 Mar 2024
Shares credited to demat
6 Mar 2024
Listing
7 Mar 2024

Grey market premium (GMP)

Updated 06 Mar 2024, 12:00 PM IST
Current GMP
₹30
+107.00%
Estimated listing price
₹58
Issue price ₹28
Highest
₹30
5 Mar
Lowest
₹12
22 Feb

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
6 Mar 2024₹30+107.00%₹58
5 Mar 2024₹30+107.00%₹58
4 Mar 2024₹25+89.00%₹53
2 Mar 2024₹25+89.00%₹53
1 Mar 2024₹25+89.00%₹53
29 Feb 2024₹17+61.00%₹45
28 Feb 2024₹17+61.00%₹45
27 Feb 2024₹15+54.00%₹43
26 Feb 2024₹15+54.00%₹43
23 Feb 2024₹15+54.00%₹43
22 Feb 2024₹12+43.00%₹40
21 Feb 2024₹17+61.00%₹45
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 10 Nov 2026, 06:44 AM IST
Overall subscription
136.99x
Fully subscribed
  • QIB189.28x
  • NII (HNI)250.39x
  • Retail58.52x

Financials

Amounts in Rs. Crore
P/E (pre-issue)
12.96
P/E (post-issue)
17.68
EPS (₹)
2.20
RoE
36.71%
RoCE
17.62%
RoNW
34.19%
PAT Margin
4.04%
Debt / Equity
1.64
NAV (₹)
5.86

Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price on profit for the FY ended 31 Mar 2023.

Period ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets641.18575.16392.30353.93
Total Income612.881,183.80776.15609.95
Profit After Tax32.9847.5325.8211.01
NET Worth159.11128.9287.2564.54
Total Borrowing317.73254.83173.50159.19

Peer comparison

CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Mukka Proteins
This IPO
₹224 Cr12.7334.19%4.04%136.99x+42.86%
Shree Tirupati Balajee Agro Trading Company
Mainboard · listed 12 Sep 2024
₹169.65 Cr18.7720.84%6.53%124.74x+8.43%
Regaal Resources
Mainboard · listed 20 Aug 2025
₹306 Cr21.9820.25%5.19%159.88x+38.24%
Nova AgriTech
Mainboard · listed 31 Jan 2024
₹143.81 Cr18.2732.08%9.73%113.21x+34.15%
Amir Chand Jagdish Kumar (Exports)
Mainboard · listed 2 Apr 2026
₹440 Cr22.5611.87%4.76%3.41x-5.66%
Crystal Crop Protection
Mainboard · Upcoming
₹455.49 Cr8.177.14%4.56%——
Sanstar
Mainboard · listed 26 Jul 2024
₹510.15 Cr25.9330.92%6.17%82.99x+14.74%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹185.81 Cr total

How Mukka Proteins plans to use the money raised, as stated in the offer document.

  1. Funding working capital requirements of the Company₹120 Cr
  2. Investment in our Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements; and₹10 Cr
  3. General Corporate Purpose₹55.81 Cr

About Mukka Proteins

Mukka Proteins Limited was incorporated in March 2003. It makes fish protein products, namely fish meal, fish oil and fish soluble paste. These are key ingredients for aqua feed for fish and shrimp, poultry feed for broilers and layers, and pet food. It also has an associate, Ento Proteins. It exports to countries such as Bahrain, Bangladesh, Chile, Indonesia, Malaysia, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan and Vietnam. Its promoters are Kalandan Mohammed Haris, Kalandan Mohammad Arif and Kalandan Mohammed Althaf. The IPO was Rs 224 crore and was entirely fresh issue. Rs 120.00 crore was planned for working capital and Rs 10.00 crore for its associate Ento Proteins.

Strengths

  • Total income rose from Rs 609.95 crore in FY2021 to Rs 1,183.80 crore in FY2023.
  • Profit after tax rose from Rs 11.01 crore in FY2021 to Rs 47.53 crore in FY2023.
  • The pre-issue P/E was 12.96 at the upper band of Rs 28, based on EPS of Rs 2.16.
  • The whole Rs 224 crore issue was fresh capital, mostly for working capital.
  • Profit after tax was Rs 32.98 crore in the six months to 30 September 2023.

Risks

  • Total borrowing rose from Rs 159.19 crore on 31 March 2021 to Rs 317.73 crore on 30 September 2023.
  • Margins are thin, and the source puts the PAT margin at 4.04%.
  • Fish supply depends on catches, fishing bans and weather, which can swing volumes and prices, as income rose from Rs 776.15 crore in FY2022.
  • Export sales add currency and trade risk, and the source puts debt to equity at 1.64.
  • Promoters and the promoter group held 99.99% before the issue and 73.33% after it.

Promoters and shareholding

Kalandan Mohammed Haris, Kalandan Mohammad Arif and Kalandan Mohammed Althaf

Promoter holding, pre-issue
99.99%
Promoter holding, post-issue
73.33%

Anchor investors

6 investors · ₹67.2 Cr raised
InvestorShares allottedAmount% of anchor book
CRAFT EMERGING MARKET FUND PCC - ELITE CAPITAL FUND35,71,660₹10 Cr14.88%
ELARA INDIA OPPORTUNITIES FUND35,71,660₹10 Cr14.88%
EMINENCE GLOBAL FUND PCC - EUBILIA CAPITAL PARTNERS FUND I39,29,040₹11 Cr16.37%
SAINT CAPITAL FUND35,73,800₹10.01 Cr14.89%
NEOMILE GROWTH FUND - SERIES I57,81,745₹16.19 Cr24.09%
ZINNIA GLOBAL FUND PCC - CELL DEWCAP FUND35,71,660₹10 Cr14.88%

Registrar, lead managers and documents

Registrar

Cameo Corporate Services Limited

044-28460390/28460391/28460392

priya@cameoindia.com

Company contact

+918244252889

cs@mukkaproteins.com

Mukka Proteins IPO: common questions

1.When does the Mukka Proteins IPO open and close?

The Mukka Proteins IPO opens on 29 Feb 2024 and closes on 4 Mar 2024.

2.What is the price band of the Mukka Proteins IPO?

The price band is ₹26 – ₹28 per share, with a lot size of 535 shares and a minimum investment of ₹14,980.

3.What is the size of the Mukka Proteins IPO?

The issue size is ₹224 Cr (Fresh capital only).

4.What is the GMP of the Mukka Proteins IPO?

The last reported grey market premium is ₹30 per share as of 06 Mar 2024, 12:00 PM IST. GMP is unofficial and changes frequently.

5.When is the Mukka Proteins IPO allotment?

The basis of allotment is expected on 5 Mar 2024. Allotment status can be checked with the registrar, Cameo Corporate Services Limited.

6.When will the Mukka Proteins IPO list?

The shares listed on 7 Mar 2024 on BSE, NSE.

7.Who is the lead manager of the Mukka Proteins IPO?

The book running lead manager is Fedex Securities Pvt. Ltd, and the registrar is Cameo Corporate Services Limited.

8.What will the money raised in the Mukka Proteins IPO be used for?

As stated in the offer document, the proceeds are for: Funding working capital requirements of the Company; Investment in our Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements; and; General Corporate Purpose.

9.How can my company launch an IPO like Mukka Proteins?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393